Captopril and Aspirin: Interaction Details
- Captopril
- Capoten
- Aspirin
- EntercoteZorprinValomag +13 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Captopril and Aspirin interaction:
Aspirin
- Entercote
- Zorprin
- Valomag
- Uni-Tren
- Uni-Buff
- Sloprin
- Ridiprin
- Minitabs
- Miniprin
- Magnaprin
- Halfprin
- Genprin
- Gennin-FC
- Genacote
- Fasprin
- Acuprin
What Happens When You Take Captopril With Aspirin
What can happen when they are taken together (rated Major)
Reduced hyponatremic and hypotensive effects of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
of aspirin and ACE inhibitors calls for caution. Because aspirin acts indirectly on the renin-angiotensin conversion pathway, giving it alongside an ACE inhibitor may blunt the hyponatremic and hypotensive effects of the ACE inhibitor.
When the two are combined, patients should have their blood pressure and function monitored.1 Aspirin suppresses prostaglandin production, including the prostaglandins responsible for vasodilator and antithrombotic activity.
In patients with heart failure, generation of vasodilator prostaglandins may serve as a significant counter-regulatory pathway. Angiotensin II is capable of stimulating vasodilator prostaglandin production, so in theory ACE inhibitor therapy could lower renal prostaglandin synthesis.
Nevertheless, how ACE inhibitors ultimately affect prostaglandin synthesis and aggregability is still a matter of debate, and the evidence regarding an aspirin and ACE inhibitor interaction is inconclusive.89 Additional research is required to establish whether this interaction takes place in patients with hypertension, coronary artery disease, or heart failure, and whether susceptibility to it is likely to differ between individuals. Research is also needed to identify the optimal aspirin dose for patients receiving ACE inhibitor therapy.10
The Captopril and Aspirin Interaction, Explained
Captopril lowers blood pressure and helps your heart and kidneys. Aspirin is often used for pain or to protect the heart. Aspirin blocks natural substances called prostaglandins, which help relax blood vessels. Because of this, aspirin may make captopril work a little less well at lowering your blood pressure. Aspirin may also affect how your kidneys work while you take both.
The good news is that this is mostly based on theory, and the research is mixed. Many people take both safely. Keep taking your medicines as prescribed. Your care team may simply check your blood pressure and kidney health more closely.
Mechanism: Aspirin inhibits COX-mediated prostaglandin synthesis, including vasodilatory prostaglandins that contribute to the antihypertensive and natriuretic effects of such as captopril. This is a interaction, not a PK interaction.
Direction: It may attenuate the hypotensive and hyponatremic effects of captopril. Magnitude and onset are not established.
Evidence: Theoretical. Clinical data are inconclusive and dose-dependence (low- vs. high-dose aspirin) is not defined. Severity on file: major.
- Use caution with .
- Monitor blood pressure and renal function (SCr, BUN).
- Consider heightened vigilance in heart failure, where prostaglandins are counter-regulatory.
See the 10 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Captopril and Aspirin Interact
The likely mechanism
of prostaglandin synthesis; aspirin-mediated indirect effects on the renin-angiotensin conversion pathway
How to Manage the Captopril and Aspirin Interaction
When captopril and aspirin are used together, your care team can manage this with closer monitoring:
- They may check your blood pressure more often to make sure captopril is still working well.
- They may check your kidney function while you take both.
- If needed, your treatment may be adjusted and individualized by your care team.
What you can do: Keep taking both medicines exactly as prescribed. Tell your pharmacist or doctor if you take aspirin, including over-the-counter aspirin. Mention any home blood pressure readings that seem higher than usual.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Captopril or Aspirin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
6 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
In patients with severe heart failure, aspirin may interfere with the hemodynamic effect of . In a double blind design, eighteen patients with severe heart failure were randomly assigned to placebo, enalapril 10 mg and placebo, or enalapril and aspirin 350 mg.
When given alone, enalapril produced significant reductions in systemic vascular resistance, left ventricular filling pressure, and total pulmonary resistance. Cardiac output was also significantly increased.
With the addition of aspirin, enalapril had no significant effect on any of these parameters. This effect of aspirin may result from interference with prostaglandin synthesis.2
-
Report 2 · Study title
Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
Data from the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) underwent a retrospective subgroup analysis to assess long-term mortality in patients receiving both aspirin and enalapril after an acute myocardial infarction (AMI). CONSENSUS II enrolled 6090 patients with AMI who received either enalapril or placebo.
The analysis compared the effect of enalapril in patients who were taking aspirin at randomization with its effect in patients who were not taking aspirin at baseline. The investigators found that, at the end of the study, aspirin antagonized the effect of enalapril on mortality. Further research is needed to confirm this interaction and its health implications.3
-
Report 3 · Study title
Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors
Thirteen patients with congestive heart failure (CHF) already on maintenance therapy took part in a randomized, cross-over study in which they received a single dose of captopril 25 mg together with either aspirin 236 mg or placebo. Patients with CHF are known to have elevated of prostaglandins I2 and E2 (PGI2, PGE2), which possess vasodilating properties.
Captopril given alone produced no significant change in plasma PGI2 and PGE2 levels, nor in the level of the vasoconstrictor thromboxane A2 (TXA2). In contrast, administration of captopril with aspirin led to significant reductions in PGE2 and TXA2, although the hemodynamic changes were similar to those observed with captopril alone. These findings suggest that aspirin use should be avoided in patients with CHF, particularly when an ACE inhibitor is also being given.4
-
Report 4 · Study title
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors
Mortality data were analyzed for 11,575 patients with coronary artery disease screened for the Bezafibrate Infarction Prevention (BIP) trial, and 1247 patients receiving therapy were identified. This group was subdivided into 618 patients receiving aspirin in addition to an ACE inhibitor and a control group of 579 patients receiving an ACE inhibitor only.
The dose and indication of the ACE inhibitor and the dose of aspirin were not recorded. At five years, 155 deaths (27%) had occurred in the control group compared with 119 deaths (19%) in the ACE inhibitor plus aspirin group.
The risk of mortality remained lower in aspirin users even after adjustment for age, medical history, and other medications. In a subgroup analysis of 464 patients with congestive heart failure (CHF) treated with an ACE inhibitor, 221 patients (48%) were receiving aspirin and 243 patients were not.
Within this subgroup, the five-year mortality rate was lower in patients taking aspirin (24%) than in those not taking aspirin (34%). These results contradict those of the SOLVD, CONSENSUS II, GUSTO-I, and GISSI-3 trials and support aspirin use in patients with coronary artery disease who are also receiving an ACE inhibitor.5
-
Report 5 · Study title
Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors
Twenty-six patients with stable congestive heart failure (CHF) secondary to idiopathic cardiomyopathy were assigned to two groups. Group 1 included 18 patients on an (enalapril 20 mg daily), and group 2 included eight patients not on ACE inhibitor therapy.
Aspirin 325 mg daily was administered consecutively for eight weeks. Pulmonary function testing was carried out to measure forced expiratory volume in 1 second (FEV1), vital capacity (VC), maximal voluntary ventilation (MVV), and diffusing lung capacity for carbon monoxide (DLCO).
In group 1, aspirin reduced exercise tolerance time, peak exercise oxygen uptake, and tidal volume, and raised the ratio of minute ventilation to carbon dioxide production. These effects were not observed in group 2, whose patients were not on an ACE inhibitor.
It appears that lung prostaglandin production is increased in CHF patients receiving ACE inhibitor therapy and that aspirin is harmful to this process. These findings may be relevant to patients with CHF due to ischemic heart disease. Whether lower aspirin doses would produce the same adverse effect on ventilatory gas exchange and exercise capacity is not known.6
-
Report 6 · Study title
Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure
A dose-related effect of aspirin may adversely affect survival in some patients taking an . A retrospective, cohort study assessed 344 patients with a principal discharge diagnosis of CHF at the Institute of Cardiology, University of Milan, between January 10, 1990 and December 31, 1999.
The study outcome was death from any cause over a maximum follow-up of 10 years (mean follow-up 3.1 years). Patients were assigned to 3 groups according to use of an ACE inhibitor alone (group 1 (n equal to 235)), an ACE inhibitor plus aspirin at 160 mg or less daily (group 2 (n equal to 45)), or an ACE inhibitor plus aspirin at 325 mg or more daily (group 3 (n equal to 64)).
After a mean follow-up of 37.6 months, 134 (39%) deaths had occurred: 84 (36%) in group 1, 15 (33%) in group 2, and 35 (55%) in group 3. Kaplan-Meier analysis showed similar survival in groups 1 and 2 and significantly (p equal to 0.009) poorer survival in group 3.
After adjustment for potential confounders (including treatment, age, smoking, and diabetes mellitus), a time dependent multivariate Cox proportional hazards regression analysis showed that the combination of an ACE inhibitor with high-dose aspirin was independently associated with the risk of death (hazard ratio, 1.03; p equal to 0.01). The combination of an ACE inhibitor with low-dose aspirin was not associated with mortality (hazard ratio, 1.02; p equal to 0.18). These results show a dose-dependent counteraction of ACE inhibitors by aspirin that may affect survival in some patients with CHF.7
Captopril and Aspirin: Common Questions
How serious is the Captopril and Aspirin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Captopril and Aspirin interaction managed?
When captopril and aspirin are used together, your care team can manage this with closer monitoring: They may check your blood pressure more often to make sure captopril is still working well. They may check your kidney function while you take both. If needed, your treatment may be adjusted and individualized by your care team. What you can do: Keep taking both medicines exactly as prescribed. Tel… Management is individual — always follow your own care team's guidance.
Who is at higher risk from the Captopril and Aspirin interaction?
The interaction record names this group as more likely to be affected:
- People with heart disease or heart failure
If this describes you, tell your pharmacist or prescriber.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Captopril and Aspirin Interaction
Ask in your own words about taking Captopril and Aspirin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (10)
- Product Information: CARISOPRODOL, ASPIRIN, CODEINE PHOSPHATE oral tablets, carisoprodol, aspirin, codeine phosphate oral tablets. Ingenus Pharmaceuticals LLC (per DailyMed), Orlando, FL, 2021. DailyMed
- Hall D, Zeitler H, & Rudolph W: Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol 1992; 20:1549-1555. PubMed
- Nguyen KN, Aursnes I, & Kjekshus J: Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). Am J Cardiol 1997; 79:115-119. DOI
- VanWijngaarden J, Smit AJ, DeGraeff PA, et al: Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1994; 23:240-245. DOI
- Leor J, Reicher-Reiss H, Goldbourt U, et al: Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 1999; 33:1920-1925. DOI
- Guazzi M, Pontone G, & Agostoni P: Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors. Am Heart J 1999; 138:254-260. DOI
- Guazzi M, Brambilla R, Reina G, et al: Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure. Arch Intern Med 2003; 163:1574-1579. DOI
- Cleland JGF, Bulpitt CJ, Falk RH, et al: Is aspirin safe for patients with heart failure?. Br Heart J 1995; 74:215-219. PubMed
- Garcia-Dorado D, Velasco Rami J, Virgos Lamela A, et al: Interaction between antiplatelet agents and ACE inhibitors in patients with acute myocardial infarction. Eur Heart J 1999; 1(suppl F):F24-F28.
- Nawarskas J & Spinler S: Update on the interaction between aspirin and angiotensin-converting enzyme inhibitors. Pharmacotherapy 2000; 20(6):698-710. PubMed
Other Serious Interactions of Captopril and Aspirin
Also serious with Captopril
- ColchicineContraindicated
- AliskirenContraindicated
- ValsartanContraindicated
- Amlodipine / ValsartanContraindicated
Also serious with Aspirin
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Captopril
- Activated CharcoalMajor
- American HelleboreMajor
- American MistletoeMajor
- AsarabaccaMajor
- Siberian CockleburMajor
- TyramineMajor
- Vitamin B6Moderate
- SodiumModerate
- + 158 more
With Aspirin
- Activated CharcoalMajor
- WineMajor
- AsarabaccaMajor
- BeerMajor
- PiracetamMajor
- Siberian CockleburMajor
- Vitamin EModerate
- SeleniumModerate
- + 239 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.